| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/11/2006 | US7026446 Chimeric antibody conjugate comprising an antigen binding region of a non-human antibody and an immunoglobulin constant region which comprises at least one CH domain or epitope thereof, where the constant region is not a naturally occurring FC fragment; useful as positive control reagents in immunoassays |
| 04/11/2006 | US7026445 Human SDF-5 protein and compositions |
| 04/11/2006 | US7026444 Comprises extracellular novel receptor advanced glycosylation endproducts (EN-RAGE) for treatment and prevention of inflammation and neurodegenerative diseases |
| 04/11/2006 | US7026443 Composition including an oligopeptide 13 residues or less in length, which comprises the sequence ATLERTEVY (SEQ ID NO:31040); use in epitope-based vaccines |
| 04/11/2006 | US7026300 One step immunization procedure for inducing a Chlamydia specific immune response |
| 04/11/2006 | US7026299 Stimulating angiogenesis enhancing the repair of connective and support tissue, promoting the attachment, fixation and stabilization of tissue implants and enhancing wound healing. |
| 04/11/2006 | US7026294 Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes |
| 04/11/2006 | US7026293 Comprising active ingredient such as atrial natriuretic peptide which can increase cGMP production by acting on natriuretic peptide receptor, and which reduces an infarct region |
| 04/11/2006 | US7026292 improving the tissue inductive activity of BMPs, especially in a jaw bone for use in periodontal or dental reconstructive procedures; inducing local tissue formation from a progenitor cell using prosthetic devices coated with the factor |
| 04/11/2006 | US7026291 Epithelial cell specific growth factor, keratinocyte growth factor (KGF) |
| 04/11/2006 | US7026288 Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin |
| 04/11/2006 | US7026286 Methods and compositions for the introduction of molecules into cells |
| 04/11/2006 | US7026283 Calcium-independent negative regulation by CD81 of receptor signalling |
| 04/11/2006 | US7026281 Antagonistic analogs of GH-RH inhibiting IGF-I and -II |
| 04/11/2006 | US7026280 Polypeptides; nervous system, brain disorders |
| 04/11/2006 | US7026158 Nucleotide sequences which code for the mikE17 gene |
| 04/11/2006 | US7026157 Bacterial hemoglobin receptor genes |
| 04/11/2006 | US7026149 for producing amino acids in microorganisms having enhanced or attenuated expression; genetic engineering |
| 04/11/2006 | US7026140 Serum paraoxonase |
| 04/11/2006 | US7026139 To regulate an immune response in an animal |
| 04/11/2006 | US7026130 screening chemical compounds for ability to compete with hepatitis C virus for binding to a HCV receptor by comparing the binding of the HCV receptor to the E2 protein of HCV in the presence of said compound to the binding of the receptor to the protein in the absence of the compound |
| 04/11/2006 | US7026128 Nucleotide sequences coding polypeptide for use as diagnostic tool in the detection of allergic response to mammalian animal dander |
| 04/11/2006 | US7026127 Reg-like protein |
| 04/11/2006 | US7026125 formed by culturing a host cell expressing both receptors; screening a ligand for its effect on an activity of a retinoid X receptor (RXR) hormone receptor heterodimer; heterodimer amplifys the activity of the hormone receptor |
| 04/11/2006 | US7026113 Veterinary medicine; vaccine containing mutant gene |
| 04/11/2006 | US7025969 Cells activated with cytomegalo virus; vaccine; gene therapy |
| 04/11/2006 | US7025968 Identifying viricidal agents which prevent cytomegalo viral infection and distribution; gene expression inhibition |
| 04/11/2006 | US7025967 Recombinant protein production in bovine adenovirus expression vector system |
| 04/11/2006 | US7025964 Peptide-based immunotherapeutic agent |
| 04/11/2006 | US7025962 Gene encoding lymphocyte surface antigen; protein or nucleic acid |
| 04/11/2006 | US7025959 Drug containing Dna coding of protein; hybrids; genetic engineering |
| 04/11/2006 | US7025515 Bit mask generation system |
| 04/11/2006 | CA2358829C Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 04/11/2006 | CA2321177C Recombinant fibronectin-based extracellular matrix for wound healing |
| 04/11/2006 | CA2259967C Peptide reagent for the detection of human cytomegalovirus (cmv) |
| 04/11/2006 | CA2204375C Methods for the diagnosis of glaucoma |
| 04/06/2006 | WO2006037038A1 Optimized vaccines to provide protection against ebola and other viruses |
| 04/06/2006 | WO2006036922A2 Srage mimetibody, compositions, methods and uses |
| 04/06/2006 | WO2006036878A2 Interleukin-9 and interleukin-4 chimeric antagonist muteins and methods of using same |
| 04/06/2006 | WO2006036877A2 Recombinant bifunctional protein of human lutropin receptor and human chorionic gonadotropin b-subunit and uses thereof |
| 04/06/2006 | WO2006036772A2 Crystallization of membrane proteins in three-dimentionally connected lipid bilayer gels |
| 04/06/2006 | WO2006036445A2 Chimeric nk receptor and methods for treating cancer |
| 04/06/2006 | WO2006036406A2 Live microbial microbicides |
| 04/06/2006 | WO2006036074A1 Myostatin isoform |
| 04/06/2006 | WO2006036002A1 Novel bone metastasis marker peptide and method of diagnosing bone metastasis by using the same |
| 04/06/2006 | WO2006035831A1 Method of producing l-arginine, l-ornithine or l-citrulline |
| 04/06/2006 | WO2006035815A1 Method of producing partial peptide of enolase protein from plasmodium falciparum |
| 04/06/2006 | WO2006035741A1 Gene expressed specifically in es cells and utilization of the same |
| 04/06/2006 | WO2006035311A2 GROUP A STREPTOCOCCUS CrgE PROTEIN |
| 04/06/2006 | WO2006035273A2 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis |
| 04/06/2006 | WO2006035060A2 Purification of a bulk of a factor vii polypeptide by fractionated elution from an anion-exchange material |
| 04/06/2006 | WO2006035058A2 Purification of a drug substance of a factor vii polypeptide by removal of desgla-factor vii polypeptide structures |
| 04/06/2006 | WO2006035057A1 Modified proteins |
| 04/06/2006 | WO2006035051A1 A bacterial atp synthase binding domain |
| 04/06/2006 | WO2006026470A3 Hiv immunostimulatory compositions |
| 04/06/2006 | WO2006013367A3 Chimeric heamaglutinin proteins and uses thereof |
| 04/06/2006 | WO2006011060A3 Polypeptides for oligomeric assembly of antigens |
| 04/06/2006 | WO2006004988A3 B7-dc binding antibody |
| 04/06/2006 | WO2006000753A3 Use of flj40787, a protein involved in colon, colorectal, ovarian, lung and/or liver cancer |
| 04/06/2006 | WO2005116076A3 Neoplasm-specific polypeptides and their uses |
| 04/06/2006 | WO2005114216A3 Stamp2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 04/06/2006 | WO2005113592A3 Interferon-alpha polypeptides and conjugates |
| 04/06/2006 | WO2005112609A3 Promotion of somatic embryogenesis in plants by pga37 gene expression |
| 04/06/2006 | WO2005111081A3 Immunoglobulin-like variable chain binding polypeptides and methods of use |
| 04/06/2006 | WO2005103269A3 Generation of plants with altered oil content |
| 04/06/2006 | WO2005100385A3 Compounds that block the c5a receptor and their use in therapy |
| 04/06/2006 | WO2005099772A3 Methods for preventing or reducing ischemia/reperfusion induced myocardial cell death |
| 04/06/2006 | WO2005079755A3 Interleukin-13 antagonist powders, spray-dried particles, and methods |
| 04/06/2006 | WO2005079434A3 Modulation of epidermal growth factor heterodimer activity |
| 04/06/2006 | WO2005077980A3 Soluble tcr-like molecules and their uses |
| 04/06/2006 | WO2005062871A3 Tat linear epitope peptides and conjugates thereof for use in therapeutic compositions and assays |
| 04/06/2006 | WO2005051799A3 Peptide increasing fusiogenic capacity of a gamete |
| 04/06/2006 | WO2005027629A3 Regulation of cardiac contractility and heart failure propensity |
| 04/06/2006 | WO2005026203A3 Dna promoters and anthrax vaccines |
| 04/06/2006 | WO2004094610A3 Wnt as a factor for cardiac myogenesis |
| 04/06/2006 | WO2004085617A3 Timp3 as vegf inhibitor |
| 04/06/2006 | WO2004076621A3 Compositions of nucleic acids for treating and detecting influenza virus |
| 04/06/2006 | WO2004013302A3 CARD11 NFkB ACTIVATING POLYPEPTIDES, NUCLEIC ACIDS, INBRED AND TRANSGENIC ANIMALS, AND METHODS OF USE THEREOF |
| 04/06/2006 | WO2003045128A3 SYNTHETIC IMMUNOGENIC BUT NON-DEPOSIT-FORMING POLYPEPTIDES AND PEPTIDES HOMOLOGOUS TO AMYLOID β, PRION PROTEIN, AMYLIN, α-SYNUCLEIN, OR POLYGLUTAMINE REPEATS FOR INDUCTION OF AN IMMUNE RESPONSE THERETO |
| 04/06/2006 | US20060075523 Abiotic stress responsive polynucleotides and polypeptides |
| 04/06/2006 | US20060075511 Muir-Torre-like syndrome in Fhit deficient mice |
| 04/06/2006 | US20060075510 Murine genomic polynucleotide sequence encoding a G-protein coupled receptor and methods of use therefor |
| 04/06/2006 | US20060074234 Isolated mammalian membrane protein genes; related reagents |
| 04/06/2006 | US20060074233 Detect binding with cells transfected with DNA |
| 04/06/2006 | US20060074232 Matrimony gene and protein |
| 04/06/2006 | US20060074231 Amino acid-containing compounds and derivatives labeled with halides and method of making |
| 04/06/2006 | US20060074230 Cartilage matrix protein fusion for use in prevention and treatment of diabetic retinopathy, edema, sepsis and blood disorders |
| 04/06/2006 | US20060074228 antibody specifically binds to a polypeptide used in modulating cell proliferation, inducing neovascularization and diagnosis of tumors |
| 04/06/2006 | US20060074227 Antibodies against PRO Polypeptides which may be overexpressed in tumors |
| 04/06/2006 | US20060074226 Pro9835 antibodies |
| 04/06/2006 | US20060074224 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060074223 isolated antibody that binds specifically to the polypeptides; PRO polypeptide |
| 04/06/2006 | US20060074222 Determination of a phosphorylation site in PPIase domain of Pin1 and uses therefor |
| 04/06/2006 | US20060074221 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060074220 isolated PRO polypeptide which is either transmembrane domain-deleted or transmembrane domain-inactivated |
| 04/06/2006 | US20060074081 Progesterone receptor structure |
| 04/06/2006 | US20060074044 Nucleotide sequences coding stem cell factors for use as therapeutic tools in treating learning and memory disorders |
| 04/06/2006 | US20060074037 Producing/evaluating a protein/polypeptide (alpha-defensin) with increased antimicrobial activity and stability to effect chemotaxis of T-cells, neutrophil recruitment, or cytokine or interleukin-8 release; immunostimulants; respiratory system disorders; inflammatory bowel disease; viricides; cancer; HIV |
| 04/06/2006 | US20060074033 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/06/2006 | US20060074023 Angiogenesis associated proteins, and nucleic acids encoding the same |